Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5595821 [patent_doc_number] => 20060159737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Pharmaceutical compositions for local administration' [patent_app_type] => utility [patent_app_number] => 11/267423 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9648 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159737.pdf [firstpage_image] =>[orig_patent_app_number] => 11267423 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267423
Pharmaceutical compositions for local administration Nov 3, 2005 Abandoned
Array ( [id] => 9977077 [patent_doc_number] => 09023384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Liposome and method for injecting substance to cell using this liposome' [patent_app_type] => utility [patent_app_number] => 11/666736 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7740 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11666736 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/666736
Liposome and method for injecting substance to cell using this liposome Nov 1, 2005 Issued
Array ( [id] => 4852568 [patent_doc_number] => 20080318311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Encapsulated Bacteriophage Formulation' [patent_app_type] => utility [patent_app_number] => 11/666706 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2972 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318311.pdf [firstpage_image] =>[orig_patent_app_number] => 11666706 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/666706
Encapsulated Bacteriophage Formulation Nov 1, 2005 Abandoned
Array ( [id] => 5858923 [patent_doc_number] => 20060228776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'PINK-1 promoter' [patent_app_type] => utility [patent_app_number] => 11/256372 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16204 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228776.pdf [firstpage_image] =>[orig_patent_app_number] => 11256372 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/256372
PINK-1 promoter Oct 20, 2005 Abandoned
Array ( [id] => 5828978 [patent_doc_number] => 20060063732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Compositions and methods for gene therapy' [patent_app_type] => utility [patent_app_number] => 11/253435 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26039 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063732.pdf [firstpage_image] =>[orig_patent_app_number] => 11253435 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/253435
Compositions and methods for gene therapy Oct 17, 2005 Abandoned
Array ( [id] => 5721268 [patent_doc_number] => 20060074043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Antisense modulation of matrix metalloproteinase 1 expression' [patent_app_type] => utility [patent_app_number] => 11/250884 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25197 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074043.pdf [firstpage_image] =>[orig_patent_app_number] => 11250884 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/250884
Antisense modulation of matrix metalloproteinase 1 expression Oct 12, 2005 Abandoned
Array ( [id] => 7499611 [patent_doc_number] => 20110262524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'LIPOSOMES WITH IMPROVED DRUG RETENTION FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/576595 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 5373 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262524.pdf [firstpage_image] =>[orig_patent_app_number] => 11576595 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576595
Liposomes with improved drug retention for treatment of cancer Oct 5, 2005 Issued
Array ( [id] => 4718720 [patent_doc_number] => 20080241242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Porous Polyelectrolyte Materials' [patent_app_type] => utility [patent_app_number] => 11/576681 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13936 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 60 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241242.pdf [firstpage_image] =>[orig_patent_app_number] => 11576681 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576681
Porous Polyelectrolyte Materials Oct 3, 2005 Abandoned
Array ( [id] => 5834709 [patent_doc_number] => 20060246540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/240891 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 78 [patent_no_of_words] => 74336 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246540.pdf [firstpage_image] =>[orig_patent_app_number] => 11240891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240891
Secreted and transmembrane polypeptides and nucleic acids encoding the same Sep 28, 2005 Abandoned
Array ( [id] => 5474288 [patent_doc_number] => 20090247454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease' [patent_app_type] => utility [patent_app_number] => 11/576339 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6412 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247454.pdf [firstpage_image] =>[orig_patent_app_number] => 11576339 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576339
Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease Sep 26, 2005 Abandoned
Array ( [id] => 13698 [patent_doc_number] => 07807647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Methods and compositions for cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/233312 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 23 [patent_no_of_words] => 23647 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807647.pdf [firstpage_image] =>[orig_patent_app_number] => 11233312 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233312
Methods and compositions for cancer therapy Sep 21, 2005 Issued
Array ( [id] => 5602349 [patent_doc_number] => 20060292694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Reporter hepatocytes and other cells for drug screening and toxicity testing' [patent_app_type] => utility [patent_app_number] => 11/233712 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12345 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292694.pdf [firstpage_image] =>[orig_patent_app_number] => 11233712 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233712
Reporter hepatocytes and other cells for drug screening and toxicity testing Sep 21, 2005 Abandoned
Array ( [id] => 5721266 [patent_doc_number] => 20060074041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Antisense and antigene therapeutics with improved binding properties and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/228705 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 32107 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074041.pdf [firstpage_image] =>[orig_patent_app_number] => 11228705 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/228705
Antisense and antigene therapeutics with improved binding properties and methods for their use Sep 15, 2005 Abandoned
Array ( [id] => 5913586 [patent_doc_number] => 20060128648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Genetic suppression and replacement' [patent_app_type] => utility [patent_app_number] => 11/224524 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 13519 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128648.pdf [firstpage_image] =>[orig_patent_app_number] => 11224524 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224524
Genetic suppression and replacement Sep 11, 2005 Abandoned
Array ( [id] => 5710983 [patent_doc_number] => 20060052328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Connective tissue growth factor-2' [patent_app_type] => utility [patent_app_number] => 11/222019 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052328.pdf [firstpage_image] =>[orig_patent_app_number] => 11222019 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222019
Connective tissue growth factor-2 Sep 8, 2005 Abandoned
Array ( [id] => 5602920 [patent_doc_number] => 20060293265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Methods involving aldose reductase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/210283 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 38143 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293265.pdf [firstpage_image] =>[orig_patent_app_number] => 11210283 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/210283
Methods involving aldose reductase inhibitors Aug 22, 2005 Abandoned
Array ( [id] => 83672 [patent_doc_number] => 07741299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Therapeutic uses of inhibitors of RTP801' [patent_app_type] => utility [patent_app_number] => 11/207119 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 27 [patent_no_of_words] => 48097 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741299.pdf [firstpage_image] =>[orig_patent_app_number] => 11207119 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/207119
Therapeutic uses of inhibitors of RTP801 Aug 15, 2005 Issued
Array ( [id] => 5051897 [patent_doc_number] => 20070032442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells' [patent_app_type] => utility [patent_app_number] => 11/198351 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18022 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032442.pdf [firstpage_image] =>[orig_patent_app_number] => 11198351 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198351
Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells Aug 7, 2005 Abandoned
Array ( [id] => 141124 [patent_doc_number] => 07687070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Reagents for intracellular delivery of macromolecules' [patent_app_type] => utility [patent_app_number] => 11/192758 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7874 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687070.pdf [firstpage_image] =>[orig_patent_app_number] => 11192758 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/192758
Reagents for intracellular delivery of macromolecules Jul 28, 2005 Issued
Array ( [id] => 5667610 [patent_doc_number] => 20060172960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity' [patent_app_type] => utility [patent_app_number] => 11/181020 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 40648 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172960.pdf [firstpage_image] =>[orig_patent_app_number] => 11181020 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181020
Therapy and diagnosis of conditions related to telomere length and/or telomerase activity Jul 11, 2005 Abandoned
Menu